Morphological heterogeneity of the simultaneous ipsilateral invasive tumor foci in breast carcinoma: A retrospective study of 418 cases of carcinomas

Pathology Research and Practice

Volumn 208, Issue 10, 2012, Pages 604-609

  Boros, Monica ^a   Marian, Cristina ^a   Moldovan, Cosmin ^a   Stolnicu, Simona ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Breast carcinoma; Multicentric; Multifocal; Prognostic parameters

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CANCER; PATHOLOGICAL ANATOMY; RETROSPECTIVE STUDY; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 84867660329     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.07.005     Document Type: Article

References (47)

1. Aebi S., Davidson T., Gruber G., et al. Primary breast cancer: ESMO Clinical Practice. Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2011, 22(Suppl. 6):vi12-vi24.
2. Andea A.A., Wallis T., Newman L.A., et al. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2002, 94:1383-1390.
3. Bozzini A., Renne G., Meneghetti L., et al. Sensitivity of imaging for multifocal-multicentric breast carcinoma. BMC Cancer 2008, 8:275.
4. Buggi F., Folli S., Curcio A., et al. Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified?. Ann. Oncol. 2012, (January). mdr570v1-mdr570.
5. Cabioglu N., Ozmen V., Kaya H., et al. Increased lymph node positivity in multifocal and multicentric breast cancer. Am. Coll. Surg. 2009, 208(1):67-74.
6. Carlson R.W., Allred D.C., Anderson B.O., et al. Invasive breast cancer: clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 2011, 9(2):136-222.
7. Choi Y., Kim E.J., Seol H., et al. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast. Hum. Pathol. 2012, 43(1):48-55.
8. Coombs N.J., Boyages J. Multifocal and multicentric breast cancer: does each focus matter?. J. Clin. Oncol. 2005, 23:7497-7502.
9. De la Haba-Rodriguez J.R., Ruiz Borrego M., Gomez Espana A., et al. Comparative study of the immunohistochemical phenotype in breast cancer and its lymph node metastatic location. Cancer Invest. 2004, 22:219-224.
10. Edge S., Byrd D., Compton C., et al. American Joint Committee on Cancer (AJCC) Cancer Staging Manual, Breast, Part VII 2010, Springer, New York, pp. 347-376. seventh ed.
11. Eeles R., Knee G., Jhavar S., et al. Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res. Treat. 2011, 129:703-716.
12. Egan R.L. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 1982, 49:1123-1130.
13. Ellis I.O., Elston C.W. Histologic grade. Breast Pathology 2006, 225-233. Elsevier, Philadelphia, PA. F.P. O'Malley, S.E. Pinder (Eds.).
14. Fish E.B., Chapman J.A., Link M.A. Assessment of tumor size for multifocal primary breast cancer. Ann. Surg. Oncol. 1998, 5:442-446.
15. Gallager H.S., Martin J.E. The study of mammary carcinoma by mammography and whole organ sectioning. Early observations. Cancer 1969, 23(4):855-873.
16. Goldhirsch A., Wood W.C., Coates A.S., et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann. Oncol. 2011, 22:1736-1747.
17. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
18. Huo L. A practical approach to grossing breast specimens. Ann. Diagn. Pathol. 2011, 15(4):291-301.
19. Jain S., Rezo A., Shadbolt B., et al. Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology 2009, 41(1):57-67.
20. Joergensen L.E., Gunnarsdottir K.A., Lanng C., et al. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001. Breast 2008, 17:587-591.
21. Katz A., Strom E., Buchholtz T., et al. The influence of pathologic tumor characteristics on loco regional recurrence rates following mastectomy. Int. J. Pediatr. Oncol. Biol. Phys. 2001, 50(3):735-742.
22. Lagios M.D. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer 1977, 40:1726-1734.
23. Lester C.S., Bose S., Chen Y.Y., et al. Protocol for the Examination of Specimen from Patients with Invasive Carcinoma of the Breast 2009, College of American Pathologists, pp. 1-53, available at: .
24. Litton J., Eralp Y., Gonzales-Angulo A., et al. Multifocal breast cancer in women ≤35 years old. Cancer 2007, 110:1445-1450.
25. Middleton L., Vlastos G., Mirza N., et al. Multicentric mammary carcinoma. Cancer 2002, 94(7):1910-1916.
26. Morgenstern L., Kaufman P.A., Friedman N. The case against tylectomy for carcinoma of the breast. The factor of multicentricity. Am. J. Surg. 1975, 130:251-258.
27. Moutafoff C., Coutant C., Bezu C., et al. Prognostic and predictive factors in multifocal breast carcinoma. Gynecol. Obstet. Fertil. 2011, 39(7-8):425-432.
28. O'Daly B.J., Sweeney K.J., Ridgway P.F., et al. The accuracy of combined versus largest diameter in staging multifocal breast cancer. J. Am. Coll. Surg. 2007, 204:282-285.
29. Pedersen L., Gunnarsdottir K.A., Rasmussen B.B., et al. The prognostic influence of multifocality in breast cancer patients. Breast 2004, 14:188-193.
30. Perry N., Broeders M., De Wolf C., et al. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis 2006, Office for Official Publications of the European Communities, Luxembourg, pp. 219-313. fourth ed.
31. Qualheim R.E., Gall E.A. Breast carcinoma with multiple sites of origin. Cancer 1957, 10:460-468.
32. Rakowsky E., Klein B., Kahan E., et al. Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res. Treat. 1992, 21:121-131.
33. Rezo A., Dahlstrom J., Shadbolt B., et al. Tumor size and survival in multicentric and multifocal breast cancer. Breast 2011, 20(3):259-263.
34. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. Am. J. Roentgenol. 2004, 183:1149-1157.
35. Sarnelli R., Squartini F. Multicentricity in breast cancer: a submacroscopic study. Pathol. Annu. 1986, 21:143-158.
36. Schwartz G.F., Patchefsky A.S., Feig S.A., et al. Clinically occult breast cancer. Multicentricity and implication for treatment. Ann. Surg. 1980, 191:8-12.
37. Sjostrom-Mattson J., Von Boguslawski K., Bengtsson N.O., et al. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer. Acta Oncol. 2009, 48:1137-1143.
38. Tavassoli F., Devilee P. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Breast and Female Genital Organs 2003, IARC Press, Lyon, pp. 10-11, Tumours of the Breast.
39. Tot T., Gere M., Pekar G., et al. Breast cancer multifocality, disease extent and survival. Hum. Pathol. 2011, 42(11):1761-1769.
40. Tot T., Pekar G., Hofmeyer S., et al. Molecular phenotypes of unifocal. Multifocal and diffuse invasive breast carcinomas. Pathol. Res. Int. 2011, 480960. PMID: 21151538.
41. Tot T. The metastatic capacity of multifocal breast carcinomas: extensive tumors versus tumors of limited extent. Hum. Pathol. 2009, 40:199-205.
42. Tot T. The clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histological sections. Cancer 2007, 110:2551-2560.
43. Ustaalioglu B.O., Bilici A., Kefeli U., et al. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients. Single Center Experience. Am. J. Clin. Oncol. 2011, 16(September):1-7.
44. Vlastos G., Rubio I.T., Mirza N.Q., et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann. Surg. Oncol. 2000, 7:581-587.
45. Weissenbacher T., Zschage M., Janni W., et al. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?. Breast Cancer Res. Treat. 2010, 122:27-34.
46. Westman-Naeser S., Bengtsson E., Eriksson O. Multifocal breast carcinoma. Am. J. Surg. 1981, 142:255-257.
47. Yerushalmi R., Kennecke H., Woods R., et al. Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res. Treat. 2009, 117(2):365-370.